Page 342 - ATP-P 11th Ed

• Bradycardia
• Urticaria
• Sedation
• Respiratory depression
• Hypotension
• Chest pain
Adverse reactions:
• Lowers seizure threshold
• Extrapyramidal symptoms, dystonia
• May exacerbate glaucoma
• May exacerbate hypertension
• Cholestatic jaundice
• Arrhythmias
Warning:
• Intra-arterial injection may result in gangrene of the affected extremity.
SECTION 3 pressors effect, epinephrine should NOT be used to treat hypotension associated with
®
• Because of the potential for promethazine (Phenergan ) to reverse epinephrine’s vaso-
promethazine (Phenergan ) overdose.
®
• Subcutaneous injection or IV infiltration may result in tissue necrosis.
Other notes:
• Store at room temperature, between 59–77° F (15–25° C).
• Protect from light.
• Use carton to protect contents from light.
• Do not use if solution is discolored or contains a precipitate.
• IV administration may be hazardous and is NOT recommended.
TMEP use: Nausea and/or Vomiting Protocol

®
Proventil – See Albuterol Inhaler
Pseudoephedrine (Sudafed )
®
Description: Adrenergic class. Primary activity though α-effects on respiratory mucosal
mem branes reducing congestion, hyperemia, edema, and minimal bronchodilation sec on-
dary to β-effects.
Indications:
• Nasal decongestant
• Adjunct in otitis media with antihistamines
Adult dose: 30–60mg q4–6hr PO
Pediatric dose:
• 6–12 years old: 30mg/dose PO q4–6hr
• 2–5 years old: 15mg/dose PO q4–6hr

332 SECTION 3 RECOMMENDED DRUG LIST (RDL)